ScottAntoniaMD

PubMed

• Differential roles of normal and lung cancer-associated fibroblasts in microvascular network formation.
  Naveen R Natesh, Pankaj Mogha, Alan Chen, Shyni Varghese, Scott J Antonia> ;APL Bioengineering. 2024 Mar 1
• Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC.
  Johan F Vansteenkiste, Jarushka Naidoo, Corinne Faivre-Finn, Mustafa Özgüroğlu, Augusto Villegas, Davey Daniel, Shuji Murakami, Rina Hui, Ki Hyeong Lee, Byoung Chul Ch...> ;JTO Clinical and Research Reports. 2024 Mar 1
• 1 citations
  Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma.
  Castaneda Puglianini, O., Ciara L Freeman, Reginald Atkins, Indumathy Varadarajan, Meghan Menges, Jeffrey Edelman, Rachid Baz, Jason Brayer, Omar Castaneda Puglianini,...> ;Clinical Cancer Research. 2023 Nov 14
• 4 citations
  Transcriptional and epigenetic regulators of human CD8T cell function identified through orthogonal CRISPR screens.
  Sean R McCutcheon, Adam M Swartz, Michael C Brown, Alejandro Barrera, Christian McRoberts Amador, Keith Siklenka, Lucas Humayun, Maria A Ter Weele, James M Isaacs, Tim...> ;Nature Genetics. 2023 Dec 1
• 4 citations
  A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer.
  Ernest Nadal, Mansoor Saleh, Santiago Ponce Aix, Maria Ochoa-de-Olza, Sandip Pravin Patel, Scott Antonia, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Shawn T Estrem,...> ;BMC Cancer. 2023 Jul 28
• A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations.
  Andreas N Saltos, Ben C Creelan, Tawee Tanvetyanon, Alberto A Chiappori, Scott J Antonia, Michael R Shafique, Milijana Ugrenovic-Petrovic, Samer Sansil, Anthony Neuger...> ;Lung Cancer. 2023 Sep 1
• Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1-Monotherapy Pretreated, Advanced NSCLC: Results From a P...
  Edward B Garon, Alexander I Spira, Sarah B Goldberg, Jamie E Chaft, Vassiliki Papadimitrakopoulou, Tina Cascone, Scott J Antonia, Julie R Brahmer, D Ross Camidge, John...> ;Journal of Thoracic Oncology. 2023 Aug 1
• 1 citations
  Orthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function.
  Sean R McCutcheon, Adam M Swartz, Michael C Brown, Alejandro Barrera, Christian McRoberts Amador, Keith Siklenka, Lucas Humayun, James M Isaacs, Timothy E Reddy, Smita...> ;Biorxiv. 2023 May 1
• 13 citations
  Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFIC.
  Jarushka Naidoo, Scott Antonia, Yi-Long Wu, Byoung Chul Cho, Piruntha Thiyagarajah, Helen Mann, Michael Newton, Corinne Faivre-Finn> ;Journal of Thoracic Oncology. 2023 May 1
• Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.
  Hong Zheng, Xiaoqing Yu, Mohammed L Ibrahim, Dana Foresman, Mengyu Xie, Joseph O Johnson, Theresa A Boyle, Brian Ruffell, Bradford A Perez, Scott J Antonia, Neal Ready...> ;Cancer Immunology Research. 2023 Apr 3
• 4 citations
  High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenocarcinoma.
  Kamran Mahmood, Parvathi Jampani, Jeffrey M Clarke, Steven Wolf, Xiaofei Wang, Momen M Wahidi, Coral X Giovacchini, Michael Dorry, Scott L Shofer, Jessica Shier, Greg ...> ;Chest. 2023 Jul 1
• 2 citations
  Trends in real-world biomarker testing and overall survival in US patients with advanced non-small-cell lung cancer.
  Ning Wu, Wenzhen Ge, Ruben Gw Quek, Michelle Gleeson, Jean-Francois Pouliot, Jessica J Jalbert, James Harnett, Scott J Antonia, Dietz, H.> ;Future Oncology. 2022 Dec 1
• 2 citations
  Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Sm...
  Casey L Liveringhouse, Kujtim Latifi, Amalin G Asous, Nghi B Lam, Stephen A Rosenberg, Thomas J Dilling, Gretchen V MacMillan, Alberto A Chiappori, Eric B Haura, Ben C...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 15
• 3 citations
  Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at un...
  Alexandra L Martin, Chase Powell, Mate Z Nagy, Patrick Innamarato, John Powers, Derek Nichols, Carmen M Anadon, Ricardo A Chaurio, Sungjune Kim, Min-Hsuan Wang, Bing G...> ;Cancer Immunology, Immunotherapy. 2023 Jun 1
• 1 citations
  Patient-Reported Distress and Clinical Outcomes with Immuno-Oncology Agents in Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Real-World Retrospective Cohort Study.
  Monica H Bodd, Susan C Locke, Steve P Wolf, Scott Antonia, Jeffrey Crawford, John Hartman, Kris W Herring, Neal E Ready, Thomas E Stinchcombe, Jesse D Troy, Chakita Wi...> ;Lung Cancer. 2023 Jan 1
• 10 citations
  Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy.
  Evgenii N Tcyganov, Emilio Sanseviero, Douglas Marvel, Thomas Beer, Hsin-Yao Tang, Peter Hembach, David W Speicher, Qianfei Zhang, Laxminarasimha R Donthireddy, Ali Mo...> ;Cancer Cell. 2022 Oct 10
• 19 citations
  IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells.
  Lily L Remsing Rix, Natalia J Sumi, Qianqian Hu, Bina Desai, Annamarie T Bryant, Xueli Li, Eric A Welsh, Bin Fang, Fumi Kinose, Brent M Kuenzi, Y Ann Chen, Scott J Ant...> ;Science Signaling. 2022 Aug 16
• Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer.
  Wenzhen Ge, Ning Wu, Ruben G W Quek, Jinjie Liu, Jean-Francois Pouliot, Jessica J Jalbert, James Harnett, Scott J Antonia, Dietz, H.> ;Advances in Therapy. 2022 Oct 1
• 2 citations
  Mistic: An open-source multiplexed image t-SNE viewer.
  Sandhya Prabhakaran, Chandler Gatenbee, Mark Robertson-Tessi, Jeffrey West, Amer A Beg, Jhanelle Gray, Scott Antonia, Robert A Gatenby, Alexander R A Anderson> ;Patterns. 2022 Jul 8
• 45 citations
  Patient-derived micro-organospheres enable clinical precision oncology.
  Shengli Ding, Carolyn Hsu, Zhaohui Wang, Naveen R Natesh, Rosemary Millen, Marcos Negrete, Nicholas Giroux, Grecia O Rivera, Anders Dohlman, Shree Bose, Tomer Rotstein...> ;Cell Stem Cell. 2022 Jun 2
• 22 citations
  Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lu...
  Alberto A Chiappori, Ben Creelan, Tawee Tanvetyanon, Jhanelle E Gray, Eric B Haura, Ram Thapa, Margaret L Barlow, Zhihua Chen, Dung Tsa Chen, Amer A Beg, Theresa A Boy...> ;Clinical Cancer Research. 2022 Jun 1
• 1 citations
  A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.
  Jeffrey M Clarke, Lin Gu, Xiaofei F Wang, Thomas E Stinchcombe, Marvaretta M Stevenson, Sundhar Ramalingam, Afreen Shariff, Jennifer Garst, Andrew B Nixon, Scott J Ant...> ;JTO Clinical and Research Reports. 2022 Jun 1
• 11 citations
  First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743.
  Arnaud Scherpereel, Scott Antonia, Yolanda Bautista, Francesco Grossi, Dariusz Kowalski, Gérard Zalcman, Anna K Nowak, Nobukazu Fujimoto, Solange Peters, Anne S Tsao, ...> ;Lung Cancer. 2022 May 1
• 15 citations
  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.
  Ramaswamy Govindan, Charu Aggarwal, Scott J Antonia, Marianne Davies, Steven M Dubinett, Andrea Ferris, Patrick M Forde, Edward B Garon, Sarah B Goldberg, Raffit Hassa...> ;Journal for Immunotherapy of Cancer. 2022 May 1
• 307 citations
  Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
  David R Spigel, Corinne Faivre-Finn, Jhanelle E Gray, David Vicente, David Planchard, Luis Paz-Ares, Johan F Vansteenkiste, Marina C Garassino, Rina Hui, Xavier Quanti...> ;Journal of Clinical Oncology. 2022 Apr 20
• Join now to see all